GlucoTrack, Inc. (GCTK) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+41454.6%

$203.62

vs $0.49 price

Levered DCF

$245.16

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-186.58

Distress zone

Rating

B-

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.18×	-7.37×	-41.04×	-295.18×	-950.61×	-1,548.66×	-1,586.44×	0×
P/B	1.23×	-12.81×	90.97×	1,059.36×	747.54×	462.42×	-3,944.52×	0×
P/S	0×	0×	0×	0×	0×	0×	26,777.25×	0×
EV / EBITDA	0.2×	-7.35×	-40.45×	-295.05×	-976.84×	-1,343.29×	-1,612.05×	-0.01×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1685.6%	15035.4%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-1690.4%	-15442.0%
Current ratio	1.61×	4.52×	3.22×	2.35×	6.91×	7.61×	0.32×	0.1×
Debt / equity	0.01×	-0.02×	0.06×	0.16×	0.05×	0.04×	-0.27×	-0.06×
Interest coverage	0×	-23.16×	0×	-1,477.33×	0×	0×	350.6×	357.5×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-685.6%	173.8%	-222.0%	-360.6%	-78.9%	-30.0%	249.0%	233.7%
Return on invested capital	-520.2%	-310.3%	-209.4%	-311.0%	-74.7%	-33.5%	-339.1%	-258.1%
Return on assets	-247.4%	-380.9%	-144.7%	-181.9%	-64.9%	-25.4%	-320.8%	-975.8%
Free cash flow yield	-440.6%	-7.6%	-2.3%	-0.3%	-0.1%	-0.1%	-0.1%	0.0%
Earnings yield	-557.0%	-13.6%	-2.4%	-0.3%	-0.1%	-0.1%	-0.1%	0.0%
Enterprise value	-$3.9M	$161.1M	$286.5M	$1.3B	$3.8B	$4.1B	$5.6B	$71.1K
Net debt / EBITDA	0.38×	0.24×	0.61×	0.48×	1.48×	3.07×	0.01×	-0.01×
Cash conversion cycle (days)	0	0	0	0	0	0	123	191